Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PHIO PHARMACEUTICALS CORP.

(PHIO)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/23/2021 07/26/2021 07/27/2021 07/28/2021 07/29/2021 Date
1.88(c) 1.78(c) 1.82(c) 1.84(c) 1.82(c) Last
226 182 471 011 562 158 97 744 67 612 Volume
-0.53% -5.32% +2.25% +1.10% -1.09% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 - - -
Net income 2021 -14,1 M - -
Net Debt 2021 - - -
P/E ratio 2021 -1,65x
Yield 2021 -
Sales 2022 50,0 M - -
Net income 2022 26,6 M - -
Net Debt 2022 - - -
P/E ratio 2022 1,82x
Yield 2022 -
Capitalization 24,6 M 24,6 M -
Capi. / Sales 2021 -
Capi. / Sales 2022 0,49x
Nbr of Employees 10
Free-Float 99,7%
More Financials
Company
Phio Pharmaceuticals Corp, formerly RXi Pharmaceuticals Corporation, is a biotechnology company. The Company is focused on developing immuno-oncology therapeutics based on its self-delivering ribonucleic acid interface (RNAi) (sd-rxRNA) therapeutic platform. The CompanyÔÇÖs focuses on developing sd-rxRNA therapeutic compounds to be used in the context of adoptive cell transfer by targeting checkpoints or other gene... 
More about the company
All news about PHIO PHARMACEUTICALS CORP.
07/07PHIO PHARMACEUTICALS : Scheduled to Participate in a Fireside Chat with H.C. Wai..
PR
06/22PHIO PHARMACEUTICALS : Reschedules Fireside Chat Hosted by H.C. Wainwright for J..
PR
06/21PHIO PHARMACEUTICALS CORP. : Submission of Matters to a Vote of Security Holders..
AQ
06/14PHIO PHARMACEUTICALS : Scheduled to Participate in Two Upcoming Investor Events ..
PR
06/14PHIO PHARMACEUTICALS : HC Wainwright Adjusts Phio Pharmaceuticals' Price Target ..
MT
06/07PHIO PHARMACEUTICALS : Presents new in vivo data at the 2021 asco annual meeting..
AQ
06/04PHIO PHARMACEUTICALS' : Study Shows Treatment With Intasyl May Induce Tumor Resp..
MT
06/04Phio Pharmaceuticals Presents New in Vivo Data At the 2021 Asco Annual Meetin..
CI
05/14PHIO PHARMACEUTICALS : Reports first quarter 2021 financial results and provides..
AQ
05/13PHIO PHARMACEUTICALS CORP. : Results of Operations and Financial Condition, Fina..
AQ
05/13PHIO PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITI..
AQ
05/13Phio Pharmaceuticals Corp. Reports Earnings Results for the First Quarter End..
CI
05/12PHIO PHARMACEUTICALS : Presents positive in vivo data at asgct showing ph-762 si..
AQ
05/11Phio Pharmaceuticals Presents Positive In Vivo Data at ASGCT Showing PH-762 S..
CI
04/10PHIO PHARMACEUTICALS : Presents Positive In Vivo Data Showing Strong Tumor Contr..
PR
More news
News in other languages on PHIO PHARMACEUTICALS CORP.

- No features available -

More news
Analyst Recommendations on PHIO PHARMACEUTICALS CORP.
More recommendations
Chart PHIO PHARMACEUTICALS CORP.
Duration : Period :
Phio Pharmaceuticals Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PHIO PHARMACEUTICALS CORP.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 1,82 $
Average target price 6,00 $
Spread / Average Target 230%
EPS Revisions
Managers and Directors
Gerrit Dispersyn President, Chief Executive Officer & Director
Caitlin Kontulis Secretary, VP-Finance & Administration
Robert J. Bitterman Chairman
Simon Fricker Vice President-Research
James Cardia Vice President-Business Operations
Sector and Competitors
1st jan.Capi. (M$)
PHIO PHARMACEUTICALS CORP.-32.34%25
MODERNA, INC.234.37%140 262
LONZA GROUP AG20.53%55 738
IQVIA HOLDINGS INC.38.81%47 028
CELLTRION, INC.-27.16%30 887
SEAGEN INC.-16.10%26 514